Optimizing Medication Use in Older Adults With Rheumatic Musculoskeletal Diseases: Deprescribing as an Approach When Less May Be More-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimizing Medication Use in Older Adults With Rheumatic Musculoskeletal Diseases: Deprescribing as an Approach When Less May Be More

Published:2022-10-24 Issue:12 Volume:4 Page:1031-1041
ISSN:2578-5745
Container-title:ACR Open Rheumatology
language:en
Short-container-title:ACR Open Rheumatology

Author:

Lee Jiha¹^ORCID,Singh Namrata²,Gray Shelly L.²,Makris Una E.³

Affiliation:

1. JUniversity of Michigan Ann Arbor

2. University of Washington Seattle

3. University of Texas Southwestern Medical Center and VA North Texas Health Care System Dallas

Funder

Centers for Disease Control and Prevention

Health Services Research and Development

National Institute on Aging

Rheumatology Research Foundation

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11503

Reference90 articles.

1. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

3. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis

4. Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy

5. Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and Factors Associated with De-escalation of Anti-TNFs in Older Adults with Rheumatoid Arthritis: A Medicare Claims-Based Observational Study;Drugs & Aging;2024-06-20

2. Enhancing the Efficacy and Safety of Methotrexate Treatment: A Focus on Drug Interactions (Review);Safety and Risk of Pharmacotherapy;2024-04-27

3. The prevalence and impact of polypharmacy in rheumatology;Rheumatology;2023-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3